Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial

Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Julius Simoni Leere, Jesper Karmisholt, Maciej Robaczyk, Simon Lykkeboe, Aase Handberg, Emilie Steinkohl, Jens Brøndum Frøkjær, Peter Vestergaard
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research